… MD Anderson was using old data to train its OEA. The same year, ie in 2017, the cancer center
closed down its project with IBM … to diagnose cancer, had also raised doubts over Watson …

… , but in particular that of AI, this paper aims to answer the following research question: … The
cost of comprehensive cancer management has not only been rising steadily as seen in the …

… Texas MD Anderson Cancer to withdraw from its partnership with … Watson Health just managed
to break even in 2018, after … expected, thus raising the question “why did IBM Watson fail …

… decision support products, like IBM’s Watson, is that if the … , then a couple of questions could
be raised. It could be that the … These questions were raised in the context of the SHIVA trial…

… As far as we know, IBM's "Watson for Oncology" is the only … , but it also introduces new concerns
that must be addressed. The … itself, artificial intelligence (AI)based technology is breaking …

… Fundamentally however, the heterogeneity of cancer and its evolutionary dynamics make
every … oncology and frames the utility of AI to cancer treatment improvements in light of cancer …

… IBM Watson for Oncology (WFO) is a cognitive computing system helping physicians quickly
identify key information in a … because there is no single right answer to the question (6,20). …

… Sloan Kettering Cancer Center or MD Anderson Cancer Center … put a serious question mark
to what Watson is known to be … expertly opinions can even break ties among themselves in …

… IBM Watson for the whole genome sequencing and analysis of cancer patients and produced
results within only four days [165]. As all these revolutionary approaches to cancer patients…

… offs persist, and concerns are raised about what is perceived … even in disease groups such
as breast cancer that have long-… protuberant example being IBM’s Watson for Oncology (WFO…